Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares OutstandingShort-Term Debt issuances
Ratios

Bristol Myers Squibb (BMYMP) Shares Outstanding (2016 - 2025)

Historic Shares Outstanding for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q2 2025 value amounting to $2.9 billion.

  • Bristol Myers Squibb's Shares Outstanding changed 0.0% to $2.9 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $2.9 billion, marking a year-over-year change of 0.0%. This contributed to the annual value of $2.9 billion for FY2024, which is 0.0% changed from last year.
  • Bristol Myers Squibb's Shares Outstanding amounted to $2.9 billion in Q2 2025, which was down 0.0% from $2.9 billion recorded in Q1 2025.
  • Over the past 5 years, Bristol Myers Squibb's Shares Outstanding peaked at $2.9 billion during Q1 2021, and registered a low of $2.9 billion during Q1 2021.
  • Over the past 5 years, Bristol Myers Squibb's median Shares Outstanding value was $2.9 billion (recorded in 2021), while the average stood at $2.9 billion.
  • Within the past 5 years, the most significant YoY rise in Bristol Myers Squibb's Shares Outstanding was 0.0% (2021), while the steepest drop was 0.0% (2021).
  • Bristol Myers Squibb's Shares Outstanding (Quarter) stood at $2.9 billion in 2021, then changed by 0.0% to $2.9 billion in 2022, then changed by 0.0% to $2.9 billion in 2023, then changed by 0.0% to $2.9 billion in 2024, then changed by 0.0% to $2.9 billion in 2025.
  • Its Shares Outstanding stands at $2.9 billion for Q2 2025, versus $2.9 billion for Q1 2025 and $2.9 billion for Q4 2024.